Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Li, Yong ^a   Basang, Zhuoma ^b   Ding, Huirong ^a   Lu, Zheming ^a   Ning, Tao ^a   Wei, Haoran ^a   Cai, Hong ^a   Ke, Yang ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b TIBET UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; MASPIN; MONOCLONAL ANTIBODY; PEPTIDE HYDROLASE INHIBITOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN LATEXIN; PROTEIN S100P; PROTEIN WFDC1; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ANTIGEN; CALCIUM BINDING PROTEIN; PC3.1 ANTIGEN; S100P PROTEIN, HUMAN; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; SMALL INTERFERING RNA; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL ANCHORAGE; CELL PROLIFERATION; CELL STRAIN BGC823; CELL STRAIN MGC803; COLONY FORMATION; CONTROLLED STUDY; CPG ISLAND; DOWN REGULATION; GENE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LXN GENE; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TUMOR GROWTH; ANIMAL; CARCINOMA; CELL GROWTH; DNA METHYLATION; DRUG SCREENING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; STOMACH TUMOR; TRANSGENE; TUMOR CELL LINE;

ANIMALS; ANTIGENS; CALCIUM-BINDING PROTEINS; CARCINOMA; CELL GROWTH PROCESSES; CELL LINE, TUMOR; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MICROARRAY ANALYSIS; NEOPLASM PROTEINS; RNA, SMALL INTERFERING; SERPINS; STOMACH NEOPLASMS; TRANSGENES; TUMOR STEM CELL ASSAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79953667589     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-121     Document Type: Article

References (30)

1. Hatanaka Y, Uratani Y, Takiguchi-Hayashi K, Omori A, Sato K, Miyamoto M, Arimatsu Y. Intracortical regionality represented by specific transcription for a novel protein, latexin. Eur J Neurosci 1994, 6(6):973-982. 10.1111/j.1460-9568.1994.tb00592.x, 7524963.
2. Normant E, Martres MP, Schwartz JC, Gros C. Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proc Natl Acad Sci USA 1995, 92(26):12225-12229. 10.1073/pnas.92.26.12225, 40329, 8618874.
3. Liu Q, Yu L, Gao J, Fu Q, Zhang J, Zhang P, Chen J, Zhao S. Cloning, tissue expression pattern and genomic organization of latexin, a human homologue of rat carboxypeptidase A inhibitor. Mol Biol Rep 2000, 27(4):241-246. 10.1023/A:1010971219806, 11455960.
4. Pallares I, Bonet R, Garcia-Castellanos R, Ventura S, Aviles FX, Vendrell J, Gomis-Ruth FX. Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc Natl Acad Sci USA 2005, 102(11):3978-3983. 10.1073/pnas.0500678102, 554826, 15738388.
5. Garcia-Castellanos R, Bonet-Figueredo R, Pallares I, Ventura S, Aviles FX, Vendrell J, Gomis-Rutha FX. Detailed molecular comparison between the inhibition mode of A/B-type carboxypeptidases in the zymogen state and by the endogenous inhibitor latexin. Cell Mol Life Sci 2005, 62(17):1996-2014. 10.1007/s00018-005-5174-4, 16091843.
6. Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, Smith P, Ke Y. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst 2002, 94(7):482-490.
7. Aagaard A, Listwan P, Cowieson N, Huber T, Ravasi T, Wells CA, Flanagan JU, Kellie S, Hume DA, Kobe B, et al. An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1. Structure 2005, 13(2):309-317. 10.1016/j.str.2004.12.013, 15698574.
8. Matsugi S, Hamada T, Shioi N, Tanaka T, Kumada T, Satomura S. Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. Clin Chim Acta 2007, 378(1-2):147-153. 10.1016/j.cca.2006.11.010, 17222396.
9. Liang Y, Jansen M, Aronow B, Geiger H, Van Zant G. The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice. Nat Genet 2007, 39(2):178-188. 10.1038/ng1938, 17220891.
10. Van Zant G, Liang Y. Natural genetic diversity as a means to uncover stem cell regulatory pathways. Ann N Y Acad Sci 2009, 1176:170-177. 10.1111/j.1749-6632.2009.04567.x, 19796245.
11. Liang Y, Van Zant G. Aging stem cells, latexin and longevity. Exp Cell Res 2008, 314(9):1962-1972. 10.1016/j.yexcr.2008.01.032, 2471873, 18374916.
12. Ke Y, Xu GW, Hagiwara K, Zhang JM, Ning T, Wang B, Su XL, Feng LY, Lu GR, Lu YY, Harris CC. Isolation and sequencing of the target genes induced by chemical carcinogen. Science in China (Series C) 1996, 26(1):85-91.
13. Harlow E, Lane D, . (Eds) Antibodies: A Laboratory Manual 1998, New York: Cold Spring Harbor Laboratory Press, (Eds).
14. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, Beach D. CDC25 phosphatases as potential human oncogenes. Science 1995, 269(5230):1575-1577. 10.1126/science.7667636, 7667636.
15. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, Fang H, Kawasaki ES, Hager J, Tikhonova IR, et al. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol 2006, 24(9):1140-1150. 10.1038/nbt1242, 16964228.
16. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994, 22(15):2990-2997. 10.1093/nar/22.15.2990, 310266, 8065911.
17. Li Y, Lu YY. Isolation of diallyl trisulfide inducible differentially expressed genes in human gastric cancer cells by modified cDNA representational difference analysis. DNA Cell Biol 2002, 21(11):771-780. 10.1089/104454902320908423, 12489988.
18. Zhu LH, Liu T, Tang H, Tian RQ, Su C, Liu M, Li X. MicroRNA-23a promotes the growth of gastric adenocarcinoma cell line MGC803 and downregulates interleukin-6 receptor. FEBS J 2010, 277(18):3726-3734. 10.1111/j.1742-4658.2010.07773.x, 20698883.
19. Liu QS, Zhang J, Liu M, Dong WG. Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer. Cancer Sci 2010, 101(8):1807-1812. 10.1111/j.1349-7006.2010.01600.x, 20500517.
20. Li Q, Wang X, Lu Z, Zhang B, Guan Z, Liu Z, Zhong Q, Gu L, Zhou J, Zhu B, et al. Polycomb CBX7 directly controls trimethylation of histone H3 at lysine 9 at the p16 locus. PLoS One 2010, 5(10):e13732. 10.1371/journal.pone.0013732, 2966406, 21060834.
21. McKenzie S, Sakamoto S, Kyprianou N. Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting AKT. Oncogene 2008, 27(57):7171-7179. 10.1038/onc.2008.321, 2725761, 18931702.
22. Cher ML, Biliran HR, Bhagat S, Meng Y, Che M, Lockett J, Abrams J, Fridman R, Zachareas M, Sheng S. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci USA 2003, 100(13):7847-7852. 10.1073/pnas.1331360100, 164676, 12788977.
23. Madar S, Brosh R, Buganim Y, Ezra O, Goldstein I, Solomon H, Kogan I, Goldfinger N, Klocker H, Rotter V. Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis 2009, 30(1):20-27. 10.1093/carcin/bgn232, 2639035, 18842679.
24. Cheng WL, Wang CS, Huang YH, Liang Y, Lin PY, Hsueh C, Wu YC, Chen WJ, Yu CJ, Lin SR, et al. Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer. Int J Cancer 2008, 123(8):1787-1796. 10.1002/ijc.23746, 18688858.
25. Whiteman HJ, Weeks ME, Dowen SE, Barry S, Timms JF, Lemoine NR, Crnogorac-Jurcevic T. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D. Cancer Res 2007, 67(18):8633-8642. 10.1158/0008-5472.CAN-07-0545, 17875703.
26. Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S. Functional evidence implicating S100P in prostate cancer progression. Int J Cancer 2008, 123(2):330-339. 10.1002/ijc.23447, 18452169.
27. Wehler TC, Frerichs K, Graf C, Drescher D, Schimanski K, Biesterfeld S, Berger MR, Kanzler S, Junginger T, Galle PR, et al. PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy. Oncol Rep 2008, 19(3):697-704.
28. Thorarinsdottir HK, Santi M, McCarter R, Rushing EJ, Cornelison R, Jales A, MacDonald TJ. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. Clin Cancer Res 2008, 14(11):3386-3394. 10.1158/1078-0432.CCR-07-1616, 2953416, 18519768.
29. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002, 21(35):5427-5440. 10.1038/sj.onc.1205600, 12154405.
30. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003, 349(21):2042-2054. 10.1056/NEJMra023075, 14627790.